• 1. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 2. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 3. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 4. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 5. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxamides
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids and derivatives Pyridinecarboxamides

Recent Advances in the Study of 6-Chloro-5-methoxypyridine-3-carboxamide (CAS: 1881320-69-9)

6-Chloro-5-methoxypyridine-3-carboxamide (CAS: 1881320-69-9) is a chemical compound of significant interest in the field of chemical biology and pharmaceutical research. Recent studies have highlighted its potential as a key intermediate in the synthesis of novel therapeutic agents, particularly in the development of kinase inhibitors and other small-molecule drugs. This research brief aims to summarize the latest findings related to this compound, focusing on its chemical properties, biological activities, and potential applications in drug discovery.

The compound's unique structural features, including the chloro and methoxy substituents on the pyridine ring, contribute to its reactivity and binding affinity with various biological targets. Recent synthetic methodologies have optimized the production of 6-Chloro-5-methoxypyridine-3-carboxamide, enabling its broader use in medicinal chemistry. Notably, its role as a precursor in the synthesis of kinase inhibitors has been extensively investigated, with promising results in preclinical models of cancer and inflammatory diseases.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers demonstrated the efficacy of derivatives of 6-Chloro-5-methoxypyridine-3-carboxamide in selectively inhibiting specific kinases involved in tumor proliferation. The study utilized structure-activity relationship (SAR) analysis to identify key modifications that enhance both potency and selectivity. These findings underscore the compound's versatility as a scaffold for drug development.

Another area of active research involves the compound's potential applications in neurodegenerative diseases. A recent preprint on bioRxiv reported that 6-Chloro-5-methoxypyridine-3-carboxamide derivatives exhibit neuroprotective effects in vitro, possibly through modulation of oxidative stress pathways. While further validation is required, these preliminary results suggest a promising avenue for future therapeutic development.

From a chemical perspective, advances in the characterization of 6-Chloro-5-methoxypyridine-3-carboxamide have been facilitated by improved analytical techniques, such as high-resolution mass spectrometry (HRMS) and nuclear magnetic resonance (NMR) spectroscopy. These tools have enabled researchers to elucidate the compound's stability, solubility, and degradation profiles, which are critical for its formulation in drug products.

In conclusion, 6-Chloro-5-methoxypyridine-3-carboxamide (CAS: 1881320-69-9) represents a valuable building block in modern drug discovery. Its diverse applications, ranging from oncology to neurology, highlight its importance in the chemical biology and pharmaceutical industries. Ongoing research is expected to further expand its utility, particularly in the design of next-generation therapeutics with improved efficacy and safety profiles.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)